SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

MYERS MARIE

(Last)

(First)

(Middle)

C/O HP INC.

1501 PAGE MILL ROAD

(Street)

PALO ALTO

94304

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/01/2015

3. Issuer Name and Ticker or Trading Symbol
HP INC [ HPQ ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Global Controller, HFS & PAO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	4,151	D
Common Stock	7,970	I	By E-Trade

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	09/27/2012⁽¹⁾	09/27/2019⁽³⁾	Common Stock	2,600	$23.59	D
Employee Stock Option (right to buy)	12/07/2012⁽¹⁾	12/07/2019⁽³⁾	Common Stock	3,006	$28.41	D
Employee Stock Option (right to buy)	12/06/2013⁽¹⁾	12/06/2020⁽³⁾	Common Stock	4,750	$13.83	D
Employee Stock Option (right to buy)	12/11/2014⁽¹⁾	12/11/2021⁽³⁾	Common Stock	5,436	$26.99	D
Employee Stock Option (right to buy)	09/17/2015⁽¹⁾	12/10/2022⁽³⁾	Common Stock	3,918	$37.36	D
Employee Stock Option (right to buy)	10/30/2016⁽²⁾	10/30/2023⁽³⁾	Common Stock	27,822	$26.96	D
Restricted Stock Units	⁽⁵⁾⁽⁶⁾	⁽⁶⁾	Common Stock	1,885.3919	⁽⁴⁾	D
Restricted Stock Units	⁽⁵⁾⁽⁷⁾	⁽⁷⁾	Common Stock	2,657.425	⁽⁴⁾	D
Restricted Stock Units	⁽⁸⁾	⁽⁸⁾	Common Stock	9,273	⁽⁴⁾	D

Explanation of Responses:

1. This option became exercisable beginning on this date.

2. This option will become exercisable in three equal annual installments beginning on this date.

3. This option is no longer exercisable beginning on this date.

4. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

5. On 07/29/15 the Issuer announced approved amendments to certain outstanding long-term incentive awards that were originally scheduled to vest between 09/18/15 and 12/31/15, to provide for the accelerated vesting on 09/17/15.

6. On 12/11/13 the reporting person was granted 5,438 restricted stock units ("RSUs"), 1,812 of which vested on 12/11/14, 1,813 of which vested early on 09/17/15, and 1,813 of which will vest on 12/11/16. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock. The number of derivative securities in column 5 includes 72.3919 vested dividend equivalent rights accrued but not released since the grant date.

7. On 12/10/14 the reporting person was granted 3,920 RSUs, 1,306 of which vested early on 09/17/15, and 1,307 of which will vest on each of 12/10/16 and 12/10/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock. The number of derivative securities in column 5 includes 43.425 vested dividend equivalent rights accrued but not released since the grant date.

8. On 10/30/15 the reporting person was granted 9,273 RSUs, 3,091 of which will vest on each of 10/30/16, 10/30/17, and 10/30/18. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock.

Remarks:

	Katie Colendich as Attorney-in-Fact for Marie Myers	11/12/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.